Lataa...
Pathogen safety of plasma‐derived products – Haemate(®) P/Humate‐P(®)
Summary. Plasma‐derived factor VIII (FVIII) and von Willebrand Factor (VWF)/FVIII concentrates have been successfully used to treat haemophilia since the late 1960s. These products are derived from pools of plasma donations that may contain viral contaminants – including hepatitis B virus (HBV), he...
Tallennettuna:
| Julkaisussa: | Haemophilia |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Blackwell Publishing Ltd
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7165962/ https://ncbi.nlm.nih.gov/pubmed/18786011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2516.2008.01852.x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|